Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000930413-19-000918
Filing Date
2019-03-11
Accepted
2019-03-11 17:01:40
Documents
66
Period of Report
2019-01-31

Document Format Files

Seq Description Document Type Size
1 c93193_10q.htm 10-Q 549436
2 c93193_ex31-1.htm EX-31.1 8906
3 c93193_ex31-2.htm EX-31.2 8850
4 c93193_ex32-1.htm EX-32.1 3069
5 c93193_ex32-2.htm EX-32.2 3085
  Complete submission text file 0000930413-19-000918.txt   3863795

Data Files

Seq Description Document Type Size
6 enz-20190131.xml EX-101.INS 803567
7 enz-20190131.xsd EX-101.SCH 54480
8 enz-20190131_cal.xml EX-101.CAL 33610
9 enz-20190131_def.xml EX-101.DEF 243441
10 enz-20190131_lab.xml EX-101.LAB 350119
11 enz-20190131_pre.xml EX-101.PRE 240116
Mailing Address ENZO BIOCHEM INC 60 EXECUTIVE BLVD FARMINGDALE NY 11735
Business Address 60 EXECUTIVE BLVD FARMINGDALE NY 11735 5167555500
ENZO BIOCHEM INC (Filer) CIK: 0000316253 (see all company filings)

EIN.: 132866202 | State of Incorp.: NY | Fiscal Year End: 0731
Type: 10-Q | Act: 34 | File No.: 001-09974 | Film No.: 19672968
SIC: 8071 Services-Medical Laboratories